226 related articles for article (PubMed ID: 33215260)
1. Genetically engineered fusion of allergen and viral-like particle induces a more effective allergen-specific immune response than a combination of them.
Sani MZ; Bargahi A; Momenzadeh N; Dehghani P; Moghadam MV; Maleki SJ; Nabipour I; Shirkani A; Akhtari J; Hesamizadeh K; Heidari S; Omrani F; Akbarzadeh S; Mohammadi M
Appl Microbiol Biotechnol; 2021 Jan; 105(1):77-91. PubMed ID: 33215260
[TBL] [Abstract][Full Text] [Related]
2. Rational Design of Hypoallergenic Vaccines: Blocking IgE-binding to Polcalcin Using Allergen-specific IgG Antibodies.
Mohammadi M; Khamisipour G; Soltanpour F; Omrani F; Taheri B; Momenzadeh N; Fouladvand M
Iran J Allergy Asthma Immunol; 2020 Jun; 19(3):276-288. PubMed ID: 32615661
[TBL] [Abstract][Full Text] [Related]
3. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
4. Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice.
Sazegari S; Akbarzadeh Niaki M; Afsharifar A; Niazi A; Derakhshandeh A; Moradi Vahdat M; Hemmati F; Eskandari MH
Microb Cell Fact; 2023 Feb; 22(1):39. PubMed ID: 36841778
[TBL] [Abstract][Full Text] [Related]
5. Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit.
Broos K; Janssens ME; De Goeyse I; Vanlandschoot P; Leroux-Roels G; Geysen D; Guisez Y
Clin Vaccine Immunol; 2008 May; 15(5):852-8. PubMed ID: 18367580
[TBL] [Abstract][Full Text] [Related]
6. Development of HBc virus-like particles as modular nanocarrier by intein-mediated trans-splicing.
Wang Z; Tang S; Yue N; Qian Z; Zhou S
Biochem Biophys Res Commun; 2021 Jan; 534():891-895. PubMed ID: 33213839
[TBL] [Abstract][Full Text] [Related]
7. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and characterization of HBc virus like particles with site-directed coupling function].
Liu D; Li B; Bi C; Qiao H; Wu X
Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1440-1449. PubMed ID: 32748602
[TBL] [Abstract][Full Text] [Related]
9. Chimeric hepatitis B virus core particles displaying Neisserial surface protein A confer protection against virulent
Hou Y; Yan T; Cao H; Liu P; Zheng K; Li Z; Deng Q; Hu S
Int J Nanomedicine; 2019; 14():6601-6613. PubMed ID: 31496701
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.
Pumpens P; Razanskas R; Pushko P; Renhof R; Gusars I; Skrastina D; Ose V; Borisova G; Sominskaya I; Petrovskis I; Jansons J; Sasnauskas K
Intervirology; 2002; 45(1):24-32. PubMed ID: 11937768
[TBL] [Abstract][Full Text] [Related]
11. Efficient Humoral and Cellular Immune Responses Induced by a Chimeric Virus-like Particle Displaying the Epitope of EV71 without Adjuvant.
Liang P; Yi Y; Su QD; Qiu F; Fan XT; Lu XX; Bi SL
Biomed Environ Sci; 2018 May; 31(5):343-350. PubMed ID: 29866216
[TBL] [Abstract][Full Text] [Related]
12. A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice.
Sominskaya I; Skrastina D; Petrovskis I; Dishlers A; Berza I; Mihailova M; Jansons J; Akopjana I; Stahovska I; Dreilina D; Ose V; Pumpens P
PLoS One; 2013; 8(9):e75938. PubMed ID: 24086668
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
14. Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
Yin Y; Zhang J; Dong D; Liu S; Guo Q; Song X; Li G; Fu L; Xu J; Chen W
Vaccine; 2008 Oct; 26(46):5814-21. PubMed ID: 18786589
[TBL] [Abstract][Full Text] [Related]
15. Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection.
Qiao L; Zhang Y; Chai F; Tan Y; Huo C; Pan Z
Antiviral Res; 2016 Jul; 131():131-40. PubMed ID: 27154395
[TBL] [Abstract][Full Text] [Related]
16. Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.
Kazaks A; Lu IN; Farinelle S; Ramirez A; Crescente V; Blaha B; Ogonah O; Mukhopadhyay T; de Obanos MP; Krimer A; Akopjana I; Bogans J; Ose V; Kirsteina A; Kazaka T; Stonehouse NJ; Rowlands DJ; Muller CP; Tars K; Rosenberg WM
BMC Biotechnol; 2017 Nov; 17(1):79. PubMed ID: 29126399
[TBL] [Abstract][Full Text] [Related]
17. HBcAg produced in transgenic tobacco triggers Th1 and Th2 response when intramuscularly delivered.
Pyrski M; Rugowska A; Wierzbiński KR; Kasprzyk A; Bogusiewicz M; Bociąg P; Samardakiewicz S; Czyż M; Kurpisz M; Pniewski T
Vaccine; 2017 Oct; 35(42):5714-5721. PubMed ID: 28917537
[TBL] [Abstract][Full Text] [Related]
18. Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.
Xu L; Li Z; Su Z; Yang Y; Ma G; Yu R; Zhang S
Vaccine; 2019 Feb; 37(7):956-964. PubMed ID: 30655174
[TBL] [Abstract][Full Text] [Related]
19. Anti-Aβ antibodies induced by Aβ-HBc virus-like particles prevent Aβ aggregation and protect PC12 cells against toxicity of Aβ1-40.
Feng G; Wang W; Qian Y; Jin H
J Neurosci Methods; 2013 Aug; 218(1):48-54. PubMed ID: 23701997
[TBL] [Abstract][Full Text] [Related]
20. Enhanced sublingual immunotherapy by TAT-fused recombinant allergen in a murine rhinitis model.
Salari F; Vahedi F; Varasteh AR; Ketabdar H; Chamani J; Sankian M
Int Immunopharmacol; 2017 Jul; 48():118-125. PubMed ID: 28501765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]